XBiotech Inc. (XBIT)
NASDAQ · Healthcare
XBiotech Inc. Revenue 2018–2023
XBiotech Inc. annual/quarterly revenue history and growth rate from 2018 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- XBiotech Inc. revenue for the quarter ending September 30, 2023 was 0, a 100.00% decrease year-over-year.
- XBiotech Inc. revenue for the twelve months ending September 30, 2023 was 1.7 M, a 84.83% decrease year-over-year.
- XBiotech Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2022.
- XBiotech Inc. annual revenue for 2022 was 4.0 M, a 78.20% decrease from 2021.
- XBiotech Inc. annual revenue for 2021 was 18.4 M, a 58.19% decrease from 2020.
- XBiotech Inc. annual revenue for 2020 was 44.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
XBiotech Inc. (XBIT) — Frequently Asked Questions
XBiotech Inc. (XBIT) is a publicly traded US company. It has a market capitalization of $71M. Explore XBIT's stock price, financial statements, earnings history, margins and key ratios below.
What is XBiotech Inc.'s market cap?
XBiotech Inc. (XBIT) has a market capitalization of $71M.
What is the XBIT stock price?
XBIT trades at $2.33 (-0.85% on the day).
Is XBIT profitable?
In fiscal 2023, XBiotech Inc. reported net income of -$25M.